Drug Database
Back to search

Finland· FI-REL-REL7508

Equanil

A meprobamate product, registered in Finland by Schering Oy. The same ATC class is registered in 3 of our 19 countries.

ATC N05BC01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEquanilATCN05BC01REGISTER NO.FI-REL-REL7508PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about EquanilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Meprobamate is registered in 3 of 19 countries.

Countries holding a registration under ATC N05BC01 (meprobamate), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose
Search meprobamate products by name

Meprobamate · ATC N05BC01

3 / 19 countries

  • Finlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
N05BC01
ATC class
Meprobamate
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

90 interactions on record for meprobamate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check meprobamate against other medicinesHow interaction checks work

Meprobamate · interactions on record

90 records

  • 4 severe
  • 60 moderate
  • 26 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05BC01

Meprobamate, as other registers publish it.

All meprobamate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db6c3d1c-7c5d-41e7-97f5-88d0855c718d
GET /v1/drugs/db6c3d1c-7c5d-41e7-97f5-88d0855c718d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.2",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "400 mg",
  "atc_label": "meprobamaatti",
  "ma_number": "1132",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7508",
  "authorised_at": "1965-03-17"
}
API referenceMCP serverPlans

See everything about meprobamate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console